Task: Answer the multiple-choice question.
Query: Which drug exhibits a 16.672% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. COc1ccc(N2CCN(c3n[nH]c(N)n3)CC2)cc1
b. CCc1cc2ccc(OC)cc2nc1SCC(=O)NNC(C)=O
c. C=CCNC(=O)C1CCC(CNc2nc(=S)[nH]c3ccccc23)CC1
Answer: c. C=CCNC(=O)C1CCC(CNc2nc(=S)[nH]c3ccccc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCNC(=O)C1CCC(CNc2nc(=S)[nH]c3ccccc23)CC1
C=CCNC(=O)C1CCC(CNc2nc(=S)[nH]c3ccccc23)CC1
N-prop-2-enyl-4-[[(2-sulfanylidene-1H-quinazolin-4-yl)amino]methyl]cyclohexane-1-carboxamide